-
Altimmune partners with DynPort on intranasal Covid-19 vaccine
pharmaceutical-technology
July 13, 2020
Biopharmaceutical firm Altimmune has signed a teaming agreement with DynPort Vaccine to support US Government funding efforts for the development of its intranasal Covid-19 vaccine candidate, AdCOVID.
-
Approved COVID-19 vaccine could be available in six months; high-risk groups should get priority access: Poll
pharmaceutical-technolog
July 13, 2020
The global spread of the COVID-19 pandemic and the resulting economic impact and public health burden has highlighted the urgent need for a vaccine to prevent the disease.
-
Panacea Biotec aims to make 1-bn doses of COVID-19 vaccine candidate in 2022
expresspharma
July 13, 2020
The company said last month it would partner with US-based Refana Inc to make a potential COVID-19 vaccine, in a collaboration that expects to have over 40 million doses available early next year.
-
International regulators align positions on phase 3 COVID-19 vaccine trials
expresspharma
July 13, 2020
The meeting participants stressed the need for large phase 3 clinical trials that enroll many thousands of people, including those with underlying medical conditions, to generate relevant data for the key target populations.
-
No compromise on rigorous evaluation for vaccine candidates: Scientific Advisor VijayRaghavan
expresspharma
July 13, 2020
India's drug regulator has given the go-ahead for trials for two vaccine candidates -- Bharat Biotech vaccine and the Zydus Cadila vaccine.
-
Pfizer, BioNTech’s COVID-19 vaccine expected to be ready for approval by year end
expresspharma
July 13, 2020
The experimental vaccine, which showed promise against the fast-spreading respiratory illness in early stage human testing, is expected to move into a large trial involving 30,000 healthy participants later this month.
-
China’s CanSino in talks for COVID vaccine Phase III trial overseas
expresspharma
July 13, 2020
Phase III trials were likely to start “pretty soon,” and the company plans to recruit 40,000 participants for the tests.
-
Russian University completes clinical trials of world’s first COVID-19 vaccine
expresspharma
July 13, 2020
The clinical trials of COVID-19 vaccine produced by Gamalei Institute of Epidemiology and Microbiology started on June 18.
-
Potential COVID-19 vaccine not ‘single solution’ to pandemic, Johnson & Johnson CEO says
expresspharma
July 10, 2020
Gorsky said it was a good thing other companies are experimenting with different approaches to vaccines, in part because different vaccines might work better in different groups of people.
-
Moderna signs deal with Spain’s Rovi to supply potential COVID-19 vaccine outside US
expresspharma
July 10, 2020
Moderna’s vaccine was among the first to be tested in humans in the United States and was found to produce protective antibodies in a small group of healthy volunteers in May.